Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis

计划入组 16 人 · 首次发布于 2024 年 11 月 14 日

Autologous Muscle Fiber Fragment Injections

计划入组 10 人 · 首次发布于 2022 年 5 月 31 日

Muscle Fiber Fragment Treatment for Urinary Incontinence

计划入组 10 人 · 首次发布于 2013 年 9 月 30 日

M-254

Recombinant human VEGF receptor-Fc fragment fusion protein (Tiantai Yinkang)

ceramide C6 fragment (TRACON)

FC-Gen Acquisition, Inc.

United States

AZIENDA SANITARIA UNIVERSITARIA FRIULI CENTRALE

Italy

Immunovant

United States

Merida Biosciences Launches with $121M to Target Disease-Causing Antibodies in Autoimmune Conditions

Nipocalimab Granted FDA Breakthrough Therapy Designation for Sjögren’s Disease

Cidara Therapeutics Presents Positive Clinical Data on CD388 for Influenza Prevention